chemocentryx inc (CCXI:NASDAQ GS)
Michael Kamm M.D.
Member of Clinical Advisory Board, ChemoCentryx, Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Prof. Michael Kamm, M.D. serves as the chairman of medicine and director Inflammatory Bowel Disease, University and St. Vincents Hospital, Melbourne (AUS). Dr. Kamm serves as a Professor of Gastroenterology and Director of Physiology Unit, St. Mark's Hospital, Harrow, England. Dr. Kamm serves as professor of gastroenterology, Karolinska Institutet, Stockholm (SWE) and head of the IBD unit, Sophiahemmet in Stockholm and chairman of the Swedish organization for the study ...
850 Maude AvenuePhone: 650-210-2900
Mountain View, California 94043
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|Erez Vigodman||Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Herve Hoppenot||Chief Executive Officer, President and Director|
|Yasuchika Hasegawa||Chairman of the Board and Chief Executive Officer|
Takeda Pharmaceutical Company Limited
|--||Compensation as of Fiscal Year 2013.|